Peer Review reports
From: OM-85 BV in pediatric recurrent respiratory tract infections: a cost-utility analysis
Original Submission | ||
---|---|---|
21 Mar 2022 | Submitted | Original manuscript |
28 Mar 2022 | Reviewed | Reviewer Report |
9 Apr 2022 | Reviewed | Reviewer Report |
16 Jun 2022 | Author responded | Author comments - Jefferson Antonio Buendia |
Resubmission - Version 2 | ||
16 Jun 2022 | Submitted | Manuscript version 2 |
19 Jul 2022 | Reviewed | Reviewer Report |
21 Jul 2022 | Author responded | Author comments - Jefferson Antonio Buendia |
Resubmission - Version 3 | ||
21 Jul 2022 | Submitted | Manuscript version 3 |
3 Aug 2022 | Reviewed | Reviewer Report |
29 Aug 2022 | Author responded | Author comments - Jefferson Antonio Buendia |
Resubmission - Version 4 | ||
29 Aug 2022 | Submitted | Manuscript version 4 |
9 Sep 2022 | Reviewed | Reviewer Report |
12 Sep 2022 | Author responded | Author comments - Jefferson Antonio Buendia |
Resubmission - Version 5 | ||
12 Sep 2022 | Submitted | Manuscript version 5 |
28 Oct 2022 | Author responded | Author comments - Jefferson Antonio Buendia |
Resubmission - Version 6 | ||
28 Oct 2022 | Submitted | Manuscript version 6 |
18 Nov 2022 | Author responded | Author comments - Jefferson Antonio Buendia |
Resubmission - Version 7 | ||
18 Nov 2022 | Submitted | Manuscript version 7 |
Publishing | ||
24 Nov 2022 | Editorially accepted | |
6 Dec 2022 | Article published | 10.1186/s12890-022-02264-9 |
You can find further information about peer review here.